Oncotherapeutics offers a comprehensive service portfolio that supports preclinical studies and clinical trials from phase I to IV. We strive to provide high quality deliverables and our clients, from small start-up biotech (16-50 employees) to large biotechnology and pharmaceuticals (10,000+ employees), enjoy the benefits of our proactive, specialized approach.
Our full suite of services include expert dedicated project teams, medical writing, data management, analysis and reporting as well as regulatory submissions. Nationally recognized research oncologists and Key Opinion Leaders in the oncology field work in parallel with our senior level clinical research teams. We have an excellent track record of short start-up times and adherence to enrollment and completion timelines.
Our history of client satisfaction and success is the best testimony of our commitment to our clients.